Marchés français ouverture 3 h 38 min

Labcorp Holdings Inc. (LH)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
207,49+1,32 (+0,64 %)
À la clôture : 04:00PM EDT
207,49 0,00 (0,00 %)
Échanges après Bourse : 06:22PM EDT

Labcorp Holdings Inc.

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein67 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Adam H. SchechterPresident, CEO & Chairman4,66MS.O.1965
Mr. Glenn A. EisenbergCFO & Executive VP1,87MS.O.1961
Mr. Mark S. SchroederExecutive VP, President of Diagnostics Laboratories & COO1,43M129,25k1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer1,3MS.O.1974
Ms. Anita Z. GrahamExecutive VP & Chief Human Resources Officer1,35MS.O.1971
Mr. Peter J. WilkinsonSenior VP & Chief Accounting OfficerS.O.S.O.1971
Mr. Lance V. BerberianExecutive VP and Chief Information & Technology Officer876,62kS.O.1963
Christin O'DonnellVice President of Investor RelationsS.O.S.O.S.O.
Ms. Sandra D. van der Vaart J.D.Executive VP, Chief Legal Officer & Corporate SecretaryS.O.S.O.1960
Ms. Amy B. SummyExecutive VP & Chief Marketing OfficerS.O.S.O.1966
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Labcorp Holdings Inc. en date du 1 juillet 2024 est 4. Les scores principaux sont Audit : 6; Société : 8; Droits des actionnaires : 1; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.